Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023

SELL
$107.32 - $113.5 $5.6 Million - $5.92 Million
-52,180 Reduced 65.45%
27,542 $3.01 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $2.15 Million - $3.93 Million
-34,521 Reduced 30.22%
79,722 $9.07 Million
Q3 2022

Nov 09, 2022

BUY
$58.92 - $84.67 $6.73 Million - $9.67 Million
114,243 New
114,243 $7.07 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.